Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-methyl-n-(1-((4-(trifluoromethyl)phenyl)methyl)-1h-indazol-3-yl)-3-furancarboxamide
1. 1807454-59-6
2. 3-furancarboxamide, 2-methyl-n-[1-[[4-(trifluoromethyl)phenyl]methyl]-1h-indazol-3-yl]-
3. Unii-1er2o3uz4w
4. 1er2o3uz4w
5. 2-methyl-n-(1-((4-(trifluoromethyl)phenyl)methyl)-1h-indazol-3-yl)-3-furancarboxamide
6. 2-methyl-n-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]furan-3-carboxamide
7. 3-furancarboxamide, 2-methyl-n-(1-((4-(trifluoromethyl)phenyl)methyl)-1h-indazol-3-yl)-
8. 2-methyl-n-[1-[[4-(trifluoromethyl)phenyl]methyl]-1h-indazol-3-yl]-3-furancarboxamide
9. 2-methyl-n-(1-((4-(trifluoromethyl)phenyl)methyl)-1h-indazol-3-yl)furan-3-carboxamide
10. 2-methyl-n-(1-{[4-(trifluoromethyl)phenyl]methyl}-1h-indazol-3-yl)furan-3-carboxamide
11. 2-methyl-n-(1-{[4-(trifluoromethyl)phenyl]methyl}indazol-3-yl)furan-3-carboxamide
12. Fascin Inhibitor Np-g2-044
13. Chembl4297473
14. Schembl17038863
15. Xllrlaabufojpc-uhfffaoysa-n
16. Dtxsid801127289
17. Ex-a3988
18. Np G2 044
19. S2962
20. Akos040759669
21. Db14995
22. Np-g2-044?
23. Da-66206
24. Ms-26765
25. Hy-125506
26. Cs-0092083
27. G17429
28. 2-methyl-n-(1-(4-(trifluoromethyl)benzyl)-1h-indazol-3-yl)furan-3-carboxamide
| Molecular Weight | 399.4 g/mol |
|---|---|
| Molecular Formula | C21H16F3N3O2 |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 60.1 |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 580 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
10
PharmaCompass offers a list of NP-G2-044 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right NP-G2-044 manufacturer or NP-G2-044 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred NP-G2-044 manufacturer or NP-G2-044 supplier.
PharmaCompass also assists you with knowing the NP-G2-044 API Price utilized in the formulation of products. NP-G2-044 API Price is not always fixed or binding as the NP-G2-044 Price is obtained through a variety of data sources. The NP-G2-044 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NP G2 044 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NP G2 044, including repackagers and relabelers. The FDA regulates NP G2 044 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NP G2 044 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NP G2 044 supplier is an individual or a company that provides NP G2 044 active pharmaceutical ingredient (API) or NP G2 044 finished formulations upon request. The NP G2 044 suppliers may include NP G2 044 API manufacturers, exporters, distributors and traders.
NP G2 044 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NP G2 044 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NP G2 044 GMP manufacturer or NP G2 044 GMP API supplier for your needs.
A NP G2 044 CoA (Certificate of Analysis) is a formal document that attests to NP G2 044's compliance with NP G2 044 specifications and serves as a tool for batch-level quality control.
NP G2 044 CoA mostly includes findings from lab analyses of a specific batch. For each NP G2 044 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NP G2 044 may be tested according to a variety of international standards, such as European Pharmacopoeia (NP G2 044 EP), NP G2 044 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NP G2 044 USP).
